Log in to save to my catalogue

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective valida...

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective valida...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7045085

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

About this item

Full title

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2020-03, Vol.20 (3), p.308-317

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Tuberculous meningitis accounts for 1–5% of tuberculosis cases. Diagnostic delay contributes to poor outcomes. We evaluated the performance of the new Xpert MTB/RIF Ultra (Xpert Ultra) for tuberculous meningitis diagnosis.
In this prospective validation study, we tested the cerebrospinal fluid (CSF) of adults presenting with suspected meningitis...

Alternative Titles

Full title

Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7045085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7045085

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(19)30550-X

How to access this item